Used in pharmaceutical synthesis as a key intermediate in Suzuki-Miyaura cross-coupling reactions to construct biaryl frameworks. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients, particularly in oncology and central nervous system drug discovery. The presence of fluorine and cyclopropyl groups enhances metabolic stability and binding affinity in target molecules. Commonly employed in late-stage functionalization due to its compatibility with diverse reaction conditions.